… in plasma were shown to decline during convalescence. Since the absence of antibodies …
B cells in convalescent individuals. Here, we report a longitudinal assessment of humoral …

… to SARS-CoV-2 in convalescent individuals have been intensely investigated for … convalescent
subjects for over 200 days, and our work represents one of the first reported longitudinal …

… a larger cohort of convalescent individuals with blood samples … In contrast to the paired
analysis at 10 weeks following acute … to normal levels by 14 weeks in convalescence (Figure 4). …

… Coronavirus disease 2019 (COVID-19) convalescent individuals carry antibodies against
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that, through a plasma …

… This prompted us to perform a longitudinal analysis of the anti-RBD antibody response in
CCP donors within a group of 15 individuals (11 males and 4 females, median age of 56 years …

… We conducted a longitudinal analysis of coronavirus disease 2019 convalescent patients, …
also decline in the majority of infected individuals [36] Indeed, analyses of the decay of SARS-…

… longitudinal analysis of the serological responses to a SARS-CoV-2 infection following
convalescence … 2 and the clinical presentation of 61 individuals. The disease severity ranged from …

… in this analysis, and each line represents one individual. … To test neutralizing efficiency of
convalescent plasma … from the early and the late convalescent phases, we tested and analysed …

… After eliminating the effects of demographic factors, we found extensive differential gene
expression up to 241 days into the convalescent period. The differentially expressed genes …

… a Estimated longitudinal trajectories for convalescent patients that were categorised into four
groups based on group-based multi-trajectory analysis. b Individual longitudinal trajectories …